SCP & CO Healthcare Acquisition Stock Forecast, Price & News

-0.01 (-0.10 %)
(As of 04/9/2021 12:00 AM ET)
Today's Range
Now: $9.75
50-Day Range N/A
52-Week Range
Now: $9.75
Volume26,755 shs
Average Volume89,062 shs
Market Capitalization$65.87 million
P/E RatioN/A
Dividend YieldN/A
SCP & CO Healthcare Acquisition Company is a blank check company. The company was incorporated in 2020 and is based in Tampa, Florida.

Industry, Sector and Symbol

Industry Shell Companies
Current SymbolNASDAQ:SHAC
Phone813 318 9600
Year FoundedN/A



Sales & Book Value

Annual SalesN/A



Market Cap$65.87 million
Next Earnings DateN/A
OptionableNot Optionable


No headlines for this company have been tracked by


Overall MarketRank

0.00 out of 5 stars

Financial Services Sector

763rd out of 793 stocks

Shell Companies Industry

373rd out of 406 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
-0.01 (-0.10 %)
(As of 04/9/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SHAC News and Ratings via Email

Sign-up to receive the latest news and ratings for SHAC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

SCP & CO Healthcare Acquisition (NASDAQ:SHAC) Frequently Asked Questions

What stocks does MarketBeat like better than SCP & CO Healthcare Acquisition?

Wall Street analysts have given SCP & CO Healthcare Acquisition a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but SCP & CO Healthcare Acquisition wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are SCP & CO Healthcare Acquisition's key executives?

SCP & CO Healthcare Acquisition's management team includes the following people:
  • Mr. Scott N. Feuer, CEO & Director
  • Mr. Bryan L. Crino, Pres & Director
  • Mr. Joseph Passero, Chief Financial Officer (Age 52)

Who are some of SCP & CO Healthcare Acquisition's key competitors?

What is SCP & CO Healthcare Acquisition's stock symbol?

SCP & CO Healthcare Acquisition trades on the NASDAQ under the ticker symbol "SHAC."

How do I buy shares of SCP & CO Healthcare Acquisition?

Shares of SHAC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is SCP & CO Healthcare Acquisition's stock price today?

One share of SHAC stock can currently be purchased for approximately $9.75.

How much money does SCP & CO Healthcare Acquisition make?

SCP & CO Healthcare Acquisition has a market capitalization of $65.87 million.

How can I contact SCP & CO Healthcare Acquisition?

The company can be reached via phone at 813 318 9600.

This page was last updated on 4/11/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.